Humalog KwikPen 200 IU/mL is a pharmaceutical grade rapid acting insulin formulation containing insulin lispro, supplied in a 5×3mL prefilled pen format. Each pen is manufactured under strict quality control standards to ensure consistent concentration, stability, and reliable batch performance.
Insulin lispro is a well established rapid acting insulin analogue widely referenced in endocrine and metabolic contexts for postprandial glucose control. The KwikPen delivery system is designed for precise dosing and convenient, controlled administration.
Key Features:
- Insulin Lispro (Humalog): Rapid acting insulin analogue
- 200 IU/mL Concentration: High strength formulation
- 5×3mL Prefilled Pens: Multi pen pharmaceutical packaging
- Fast Onset Profile: Designed for rapid glucose response
- Pharmaceutical Grade Quality: Manufactured to strict standards
- Secure Packaging: Prefilled pen system for integrity and convenience
Each pen pack is clearly labeled with full specifications for easy identification and comparison. This product is intended for pharmaceutical reference and controlled use environments and is supplied in a premium format for consistent sourcing and verified composition.
